Synonyms: compound 4 [Ng et al., 2013] [5] | GSK2245840 | SRT-2104
Compound class:
Synthetic organic
Comment: SRT2104 (GSK2245840) is an investigational, selective and orally available SIRT1 activator [4-5].
|
|
No information available. |
Summary of Clinical Use |
SRT2104 has completed Phase 2 trials in type 2 diabetes [1] and psoriasis (NCT01154101) [3], and Phase 1 studies for ulcerative colitis (where it did not demonstrate significant clinical activity in mild to moderately active UC) [6], sepsis, muscular atrophy and COPD. |